Intrinsic value of Mallinckrodt - MNK

Previous Close

$31.43

  Intrinsic Value

$127.73

stock screener

  Rating & Target

str. buy

+306%

Previous close

$31.43

 
Intrinsic value

$127.73

 
Up/down potential

+306%

 
Rating

str. buy

We calculate the intrinsic value of MNK stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 2.6

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  5.30
  5.27
  5.24
  5.22
  5.20
  5.18
  5.16
  5.14
  5.13
  5.12
  5.10
  5.09
  5.08
  5.08
  5.07
  5.06
  5.06
  5.05
  5.05
  5.04
  5.04
  5.03
  5.03
  5.03
  5.02
  5.02
  5.02
  5.02
  5.02
  5.01
Revenue, $m
  3,392
  3,571
  3,758
  3,954
  4,160
  4,375
  4,601
  4,838
  5,086
  5,346
  5,619
  5,905
  6,206
  6,521
  6,851
  7,198
  7,562
  7,944
  8,344
  8,765
  9,206
  9,670
  10,156
  10,667
  11,202
  11,765
  12,355
  12,975
  13,626
  14,309
Variable operating expenses, $m
  2,713
  2,794
  2,879
  2,968
  3,061
  3,158
  3,261
  3,368
  3,481
  3,599
  2,548
  2,678
  2,814
  2,957
  3,107
  3,264
  3,429
  3,602
  3,784
  3,975
  4,175
  4,385
  4,605
  4,837
  5,080
  5,335
  5,603
  5,884
  6,179
  6,489
Fixed operating expenses, $m
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
Total operating expenses, $m
  2,712
  2,793
  2,878
  2,967
  3,060
  3,157
  3,260
  3,367
  3,480
  3,598
  2,547
  2,677
  2,813
  2,956
  3,106
  3,263
  3,428
  3,601
  3,782
  3,973
  4,173
  4,383
  4,603
  4,835
  5,078
  5,333
  5,601
  5,882
  6,177
  6,487
Operating income, $m
  681
  778
  881
  988
  1,100
  1,218
  1,341
  1,471
  1,606
  1,749
  3,072
  3,229
  3,393
  3,565
  3,746
  3,935
  4,134
  4,343
  4,562
  4,792
  5,033
  5,286
  5,552
  5,831
  6,124
  6,432
  6,754
  7,093
  7,449
  7,822
EBITDA, $m
  2,302
  2,423
  2,550
  2,683
  2,822
  2,968
  3,121
  3,282
  3,450
  3,627
  3,812
  4,006
  4,210
  4,423
  4,647
  4,883
  5,129
  5,388
  5,660
  5,946
  6,245
  6,559
  6,889
  7,235
  7,599
  7,980
  8,381
  8,801
  9,243
  9,706
Interest expense (income), $m
  0
  391
  416
  443
  472
  502
  533
  566
  601
  637
  675
  715
  756
  800
  846
  894
  945
  998
  1,054
  1,112
  1,173
  1,238
  1,305
  1,376
  1,450
  1,528
  1,610
  1,696
  1,787
  1,881
  1,981
Earnings before tax, $m
  290
  362
  437
  516
  598
  685
  775
  870
  969
  1,074
  2,357
  2,472
  2,593
  2,719
  2,851
  2,990
  3,136
  3,289
  3,450
  3,619
  3,796
  3,981
  4,176
  4,381
  4,596
  4,821
  5,058
  5,307
  5,568
  5,842
Tax expense, $m
  78
  98
  118
  139
  162
  185
  209
  235
  262
  290
  637
  667
  700
  734
  770
  807
  847
  888
  931
  977
  1,025
  1,075
  1,128
  1,183
  1,241
  1,302
  1,366
  1,433
  1,503
  1,577
Net income, $m
  212
  265
  319
  377
  437
  500
  566
  635
  708
  784
  1,721
  1,805
  1,893
  1,985
  2,081
  2,183
  2,289
  2,401
  2,518
  2,642
  2,771
  2,906
  3,049
  3,198
  3,355
  3,520
  3,692
  3,874
  4,064
  4,264

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  15,420
  16,232
  17,083
  17,975
  18,909
  19,888
  20,914
  21,990
  23,118
  24,301
  25,541
  26,842
  28,207
  29,639
  31,141
  32,717
  34,371
  36,107
  37,929
  39,841
  41,847
  43,953
  46,164
  48,484
  50,920
  53,477
  56,161
  58,979
  61,937
  65,043
Adjusted assets (=assets-cash), $m
  15,420
  16,232
  17,083
  17,975
  18,909
  19,888
  20,914
  21,990
  23,118
  24,301
  25,541
  26,842
  28,207
  29,639
  31,141
  32,717
  34,371
  36,107
  37,929
  39,841
  41,847
  43,953
  46,164
  48,484
  50,920
  53,477
  56,161
  58,979
  61,937
  65,043
Revenue / Adjusted assets
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
  0.220
Average production assets, $m
  7,144
  7,521
  7,915
  8,328
  8,761
  9,215
  9,690
  10,188
  10,711
  11,259
  11,834
  12,436
  13,069
  13,732
  14,428
  15,159
  15,925
  16,729
  17,573
  18,459
  19,389
  20,364
  21,389
  22,464
  23,592
  24,777
  26,021
  27,326
  28,697
  30,136
Working capital, $m
  139
  146
  154
  162
  171
  179
  189
  198
  209
  219
  230
  242
  254
  267
  281
  295
  310
  326
  342
  359
  377
  396
  416
  437
  459
  482
  507
  532
  559
  587
Total debt, $m
  7,173
  7,644
  8,138
  8,655
  9,197
  9,764
  10,360
  10,983
  11,638
  12,324
  13,043
  13,798
  14,589
  15,420
  16,291
  17,205
  18,165
  19,171
  20,228
  21,337
  22,501
  23,722
  25,004
  26,350
  27,763
  29,246
  30,803
  32,437
  34,153
  35,954
Total liabilities, $m
  8,943
  9,415
  9,908
  10,425
  10,967
  11,535
  12,130
  12,754
  13,408
  14,094
  14,814
  15,568
  16,360
  17,190
  18,062
  18,976
  19,935
  20,942
  21,999
  23,108
  24,271
  25,493
  26,775
  28,121
  29,534
  31,017
  32,574
  34,208
  35,924
  37,725
Total equity, $m
  6,476
  6,818
  7,175
  7,549
  7,942
  8,353
  8,784
  9,236
  9,709
  10,206
  10,727
  11,274
  11,847
  12,448
  13,079
  13,741
  14,436
  15,165
  15,930
  16,733
  17,576
  18,460
  19,389
  20,363
  21,386
  22,460
  23,588
  24,771
  26,014
  27,318
Total liabilities and equity, $m
  15,419
  16,233
  17,083
  17,974
  18,909
  19,888
  20,914
  21,990
  23,117
  24,300
  25,541
  26,842
  28,207
  29,638
  31,141
  32,717
  34,371
  36,107
  37,929
  39,841
  41,847
  43,953
  46,164
  48,484
  50,920
  53,477
  56,162
  58,979
  61,938
  65,043
Debt-to-equity ratio
  1.110
  1.120
  1.130
  1.150
  1.160
  1.170
  1.180
  1.190
  1.200
  1.210
  1.220
  1.220
  1.230
  1.240
  1.250
  1.250
  1.260
  1.260
  1.270
  1.280
  1.280
  1.290
  1.290
  1.290
  1.300
  1.300
  1.310
  1.310
  1.310
  1.320
Adjusted equity ratio
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420
  0.420

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  212
  265
  319
  377
  437
  500
  566
  635
  708
  784
  1,721
  1,805
  1,893
  1,985
  2,081
  2,183
  2,289
  2,401
  2,518
  2,642
  2,771
  2,906
  3,049
  3,198
  3,355
  3,520
  3,692
  3,874
  4,064
  4,264
Depreciation, amort., depletion, $m
  1,621
  1,644
  1,669
  1,695
  1,722
  1,750
  1,780
  1,811
  1,844
  1,878
  740
  777
  817
  858
  902
  947
  995
  1,046
  1,098
  1,154
  1,212
  1,273
  1,337
  1,404
  1,475
  1,549
  1,626
  1,708
  1,794
  1,883
Funds from operations, $m
  1,833
  1,909
  1,988
  2,072
  2,159
  2,250
  2,346
  2,446
  2,551
  2,662
  2,461
  2,582
  2,709
  2,843
  2,983
  3,130
  3,285
  3,447
  3,617
  3,795
  3,983
  4,179
  4,386
  4,602
  4,830
  5,068
  5,319
  5,582
  5,858
  6,148
Change in working capital, $m
  7
  7
  8
  8
  8
  9
  9
  10
  10
  11
  11
  12
  12
  13
  14
  14
  15
  16
  16
  17
  18
  19
  20
  21
  22
  23
  24
  25
  27
  28
Cash from operations, $m
  1,826
  1,902
  1,981
  2,064
  2,150
  2,241
  2,337
  2,437
  2,541
  2,651
  2,449
  2,570
  2,697
  2,830
  2,970
  3,116
  3,270
  3,431
  3,600
  3,778
  3,964
  4,160
  4,366
  4,581
  4,808
  5,045
  5,295
  5,556
  5,831
  6,120
Maintenance CAPEX, $m
  -424
  -447
  -470
  -495
  -521
  -548
  -576
  -606
  -637
  -669
  -704
  -740
  -777
  -817
  -858
  -902
  -947
  -995
  -1,046
  -1,098
  -1,154
  -1,212
  -1,273
  -1,337
  -1,404
  -1,475
  -1,549
  -1,626
  -1,708
  -1,794
New CAPEX, $m
  -358
  -377
  -394
  -413
  -433
  -454
  -475
  -498
  -523
  -548
  -575
  -603
  -632
  -663
  -696
  -730
  -766
  -804
  -844
  -886
  -930
  -976
  -1,024
  -1,075
  -1,129
  -1,185
  -1,244
  -1,306
  -1,371
  -1,439
Cash from investing activities, $m
  -782
  -824
  -864
  -908
  -954
  -1,002
  -1,051
  -1,104
  -1,160
  -1,217
  -1,279
  -1,343
  -1,409
  -1,480
  -1,554
  -1,632
  -1,713
  -1,799
  -1,890
  -1,984
  -2,084
  -2,188
  -2,297
  -2,412
  -2,533
  -2,660
  -2,793
  -2,932
  -3,079
  -3,233
Free cash flow, $m
  1,044
  1,079
  1,116
  1,156
  1,197
  1,240
  1,285
  1,332
  1,382
  1,434
  1,171
  1,228
  1,287
  1,350
  1,415
  1,484
  1,556
  1,632
  1,711
  1,794
  1,881
  1,973
  2,069
  2,169
  2,275
  2,386
  2,502
  2,625
  2,753
  2,887
Issuance/(repayment) of debt, $m
  438
  471
  494
  517
  542
  568
  595
  624
  654
  686
  719
  755
  792
  830
  871
  914
  959
  1,007
  1,057
  1,109
  1,164
  1,222
  1,282
  1,346
  1,413
  1,483
  1,557
  1,634
  1,716
  1,801
Issuance/(repurchase) of shares, $m
  107
  77
  38
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  545
  548
  532
  517
  542
  568
  595
  624
  654
  686
  719
  755
  792
  830
  871
  914
  959
  1,007
  1,057
  1,109
  1,164
  1,222
  1,282
  1,346
  1,413
  1,483
  1,557
  1,634
  1,716
  1,801
Total cash flow (excl. dividends), $m
  1,589
  1,627
  1,648
  1,673
  1,739
  1,808
  1,880
  1,956
  2,036
  2,120
  1,890
  1,982
  2,079
  2,180
  2,287
  2,398
  2,515
  2,638
  2,767
  2,903
  3,045
  3,194
  3,351
  3,515
  3,688
  3,869
  4,059
  4,259
  4,469
  4,689
Retained Cash Flow (-), $m
  -319
  -341
  -357
  -374
  -392
  -411
  -431
  -452
  -474
  -497
  -521
  -546
  -573
  -601
  -631
  -662
  -695
  -729
  -765
  -803
  -843
  -885
  -928
  -975
  -1,023
  -1,074
  -1,127
  -1,184
  -1,242
  -1,304
Prev. year cash balance distribution, $m
  365
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  1,635
  1,285
  1,291
  1,298
  1,346
  1,397
  1,449
  1,505
  1,562
  1,623
  1,369
  1,436
  1,506
  1,579
  1,656
  1,736
  1,821
  1,909
  2,002
  2,100
  2,202
  2,310
  2,422
  2,541
  2,665
  2,795
  2,932
  3,075
  3,226
  3,384
Discount rate, %
  7.40
  7.77
  8.16
  8.57
  8.99
  9.44
  9.92
  10.41
  10.93
  11.48
  12.05
  12.66
  13.29
  13.95
  14.65
  15.38
  16.15
  16.96
  17.81
  18.70
  19.63
  20.62
  21.65
  22.73
  23.87
  25.06
  26.31
  27.63
  29.01
  30.46
PV of cash for distribution, $m
  1,522
  1,107
  1,020
  935
  875
  813
  748
  681
  614
  547
  392
  344
  297
  254
  213
  176
  143
  114
  89
  68
  51
  37
  27
  19
  13
  8
  5
  3
  2
  1
Current shareholders' claim on cash, %
  97.6
  96.0
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2
  95.2

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.

FINANCIAL RATIOS  of  Mallinckrodt (MNK)

Valuation Ratios
P/E Ratio -21.5
Price to Sales 4
Price to Book 0.7
Price to Tangible Book
Price to Cash Flow 16.8
Price to Free Cash Flow 25.1
Growth Rates
Sales Growth Rate -75.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -64.5%
Cap. Spend. - 3 Yr. Gr. Rate -12.7%
Financial Strength
Quick Ratio 1
Current Ratio 0.2
LT Debt to Equity 118%
Total Debt to Equity 123.4%
Interest Coverage 0
Management Effectiveness
Return On Assets -1%
Ret/ On Assets - 3 Yr. Avg. 4.2%
Return On Total Capital -1.4%
Ret/ On T. Cap. - 3 Yr. Avg. 2.5%
Return On Equity -3%
Return On Equity - 3 Yr. Avg. 5.2%
Asset Turnover 0.1
Profitability Ratios
Gross Margin 53.7%
Gross Margin - 3 Yr. Avg. 54.8%
EBITDA Margin -11.6%
EBITDA Margin - 3 Yr. Avg. 21.1%
Operating Margin -24.9%
Oper. Margin - 3 Yr. Avg. 1.8%
Pre-Tax Margin -36%
Pre-Tax Margin - 3 Yr. Avg. -8.5%
Net Profit Margin -18.4%
Net Profit Margin - 3 Yr. Avg. 3.9%
Effective Tax Rate 40.8%
Eff/ Tax Rate - 3 Yr. Avg. -63.5%
Payout Ratio 0%

MNK stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the MNK stock intrinsic value calculation we used $3221.6 million for the last fiscal year's total revenue generated by Mallinckrodt. The default revenue input number comes from 0001 income statement of Mallinckrodt. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our MNK stock valuation model: a) initial revenue growth rate of 5.3% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.4%, whose default value for MNK is calculated based on our internal credit rating of Mallinckrodt, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Mallinckrodt.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of MNK stock the variable cost ratio is equal to 81.8%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $-1 million in the base year in the intrinsic value calculation for MNK stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.8% for Mallinckrodt.

Corporate tax rate of 27% is the nominal tax rate for Mallinckrodt. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the MNK stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for MNK are equal to 210.6%.

Life of production assets of 16 years is the average useful life of capital assets used in Mallinckrodt operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for MNK is equal to 4.1%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $6522 million for Mallinckrodt - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 83.209 million for Mallinckrodt is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Mallinckrodt at the current share price and the inputted number of shares is $2.6 billion.

RELATED COMPANIES Price Int.Val. Rating
LNTH Lantheus Holdi 16.49 10.29  sell
PFE Pfizer 43.21 34.10  hold
JNJ Johnson&Johnso 144.50 176.79  buy
TEVA Teva Pharmaceu 22.62 40.23  str.buy

COMPANY NEWS

▶ Mallinckrodt Stock Can Rally Another 27%, Says Analyst   [Nov-19-18 12:33PM  Barrons.com]
▶ Which Pharmaceutical Stocks Are Outperforming All Other Stocks?   [Nov-13-18 12:51PM  Investor's Business Daily]
▶ Company News For Nov 7, 2018   [09:44AM  Zacks]
▶ Wall Street Advances on Tuesday   [12:38PM  GuruFocus.com]
▶ Mallinckrodt: 3Q Earnings Snapshot   [06:52AM  Associated Press]
▶ Q3 Earnings Preview For Mallinckrodt   [Nov-05-18 01:17PM  Benzinga]
▶ Republic Services sues Mallinckrodt in wake of EPA plan for landfill   [Oct-24-18 12:27PM  American City Business Journals]
▶ How St. Louis stocks weathered this weeks tumble   [Oct-12-18 01:37PM  American City Business Journals]
▶ Today's market winners & losers   [Oct-04-18 05:26PM  Yahoo Finance Video]
▶ 13 of the Cheapest Healthcare Stocks   [Aug-14-18 09:36AM  Motley Fool]
▶ Company News For Aug 8, 2018   [10:45AM  Zacks]
▶ Why Mallinckrodt PLC Stock Is Surging 23% Today   [Aug-07-18 11:44AM  Motley Fool]
▶ Mallinckrodt: 2Q Earnings Snapshot   [06:34AM  Associated Press]
▶ Mallinckrodt Plc to Host Earnings Call   [06:30AM  ACCESSWIRE]
▶ Mallinckrodt Launches Scientific Advisory Council   [Jun-21-18 04:45PM  PR Newswire]
▶ GoPro Is Among Seven Stocks Poised for a Reversal   [Jun-11-18 01:00PM  TheStreet.com]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.